Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2007
11/20/2007US7297476 Method of monitoring HIV assembly and maturation
11/20/2007US7296690 Method and device for inactivating viruses
11/20/2007CA2538966C Electrochemical cell
11/20/2007CA2291440C Length determination of nucleic acid repeat sequences by discontinuous primer extension
11/20/2007CA2221250C A sample presentation apparatus for mass spectrometry
11/20/2007CA1341561C Manufacture and expression of large structural genes
11/17/2007CA2587319A1 Cmklr regulation of adipogenesis and adipocyte metabolic function
11/15/2007WO2007131202A2 Genomics of in-stent restenosis
11/15/2007WO2007131135A2 Evaluating genetic disorders
11/15/2007WO2007131108A2 Method to diagnose and increase fertility of mammalian semen using dnase as diagnostic marker and therapeutic agent
11/15/2007WO2007131103A2 Direct printing of patterned hydrophobic wells
11/15/2007WO2007130967A2 Novel oligonucleotide primers and methods for dna replication
11/15/2007WO2007130951A2 Methods and apparatus for sequential amplification reactions
11/15/2007WO2007130726A2 Methods for the detection of cancer
11/15/2007WO2007130650A2 Methods for calculating codon pair-based translational kinetics values, and methods for generating polypeptide-encoding nucleotide sequences from such values
11/15/2007WO2007130636A2 Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
11/15/2007WO2007130627A2 Il-33 in the treatment and diagnosis of diseases and disorders
11/15/2007WO2007130606A2 Analyzing translational kinetics using graphical displays of translational kinetics values of codon pairs
11/15/2007WO2007130590A2 Men1 is a marker and therapeutic target for breast and prostate cancer
11/15/2007WO2007130469A2 Induction of intracellular and secreted growth inhibitors and paracrine tumor-suppressive activity by rar ligands
11/15/2007WO2007130461A2 Advanced selective plating media
11/15/2007WO2007130431A2 FUNCTION OF ESTROGEN RELATED RECEPTOR GAMMA (ERRγ) IN INCREASING MITOCHONDRIAL BIOGENESIS
11/15/2007WO2007130423A2 Biological markers of chronic wound tissue and methods of using for criteria in surgical debridement
11/15/2007WO2007130403A2 REGULATION OF ApoB BY Hspl 10 PROTEINS AND RELATED COMPOSITIONS AND METHODS
11/15/2007WO2007130399A2 Method of determining genetic predisposition for deficiency in health functions using snp analysis
11/15/2007WO2007130050A1 Hybrid cells for treating early and late stage-ned melanoma
11/15/2007WO2007129858A1 Novel use of mln51 gene and protein
11/15/2007WO2007129778A1 Method for amplifying unknown dna sequence adjacent to known sequence
11/15/2007WO2007129628A1 Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare by using the primer and probe
11/15/2007WO2007129598A1 Method for screening of substance capable of increasing glutathione
11/15/2007WO2007129428A1 Method for isolation of stem cell
11/15/2007WO2007129219A2 Polymorphisms in growth hormone receptor, ghrelin, leptin, neuropeptide y, and uncoupling protein 2 genes and their associations with measures of performance and carcass merit in beef cattle
11/15/2007WO2007129113A2 Phenotype prediction
11/15/2007WO2007129000A2 Method for determining copy number
11/15/2007WO2007128984A2 Breast cancer makers
11/15/2007WO2007128980A1 A protease detection product
11/15/2007WO2007128976A1 Lipovrotein senso
11/15/2007WO2007128916A1 Detection of venous thromboembolic diseases by measurement of d-dimers and soluble fibrin levels
11/15/2007WO2007128884A1 Novel genes and markers in type 2 diabetes and obesity
11/15/2007WO2007128550A1 Biocompatible three dimensional matrix for the immobilization of biological substances
11/15/2007WO2007128430A1 Molecular beacons for dna-photography
11/15/2007WO2007128429A1 Biomarkers for endometrial proliferation
11/15/2007WO2007128244A1 Method, oligonucleotide probe and test kit of predicting risk of negative pregnancy outcomes, and use thereof
11/15/2007WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007WO2007128080A1 An assay for modulators of apoptosis
11/15/2007WO2007107590A3 Fad-2 mutants and high oleic plants
11/15/2007WO2007106603A9 Specific labeling of proteins with zinc finger tags and use of zinc-finger-tagged proteins for analysis
11/15/2007WO2007106472A3 Non-mccj25-related lariat-peptide inhibitors of bacterial rna polymerase
11/15/2007WO2007104763A9 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2
11/15/2007WO2007104571A3 Method and test kit for diagnosing and/or making predictions about and/or estimating the effectiveness of therapeutic agents during the treatment of ovarian cancer, and method for planning an ovarian cancer treatment
11/15/2007WO2007101664A3 Improved aspergillosis test in clinical samples
11/15/2007WO2007100911A3 Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
11/15/2007WO2007100637A3 Methods for mutation detection
11/15/2007WO2007099254A3 Method for identifying at least two groups of microorganisms
11/15/2007WO2007095045A3 Electronic detection immunoassays that utilize a binder support medium
11/15/2007WO2007089880A3 Method to detect breast cancer cells
11/15/2007WO2007089145A3 Disease specific aso-probes for the detection of alpha- and beta-thalassemia mutations
11/15/2007WO2007086935A3 Methods of amplifying and sequencing nucleic acids
11/15/2007WO2007084485A3 Markers for assessing copd-related diseases
11/15/2007WO2007084002A3 Antibiotics and methods for producing them.
11/15/2007WO2007076143A3 Species-specific primer sets and identification of species-specific dna sequences using genome fragment enrichment
11/15/2007WO2007071347A3 Selective marking of immunoglobulin glycans
11/15/2007WO2007068725B1 Biochip self-calibration process
11/15/2007WO2007060002A3 Method for the individualised prognosis, recommendation and/or monitoring of therapy and/or after-care of a tumorous disease
11/15/2007WO2007058986A3 Methods for diagnosing and identifying effective therapeutics for major depressive disorder
11/15/2007WO2007056680A3 Methods and arrays for identifying human microflora
11/15/2007WO2007047912A3 Compositions and methods to detect legionella pneumophila nucleic acid
11/15/2007WO2007047572A3 Methods for identifying multiple dna alteration markers in a large background of wild-type dna
11/15/2007WO2007046095A3 Methods for testing the integrity of membranes and optically or electrochemically detectable nanoprobes thereof
11/15/2007WO2007044057A3 Methods for quantifying microrna precursors
11/15/2007WO2007038501A3 Rheumatoid arthritis markers
11/15/2007WO2007035881A3 Apparatus and method for solid-phase kinetic analysis of templated elongation reactions
11/15/2007WO2007035651A3 Systemic lupus erythematosus diagnostic assay
11/15/2007WO2007020632A3 Methods and compositions for determining a level of biologically active serum paraoxonase
11/15/2007WO2007011392A3 Crystal structure of domain 111 of west nile virus envelope protein-fab fragment of neutralizing antibody complex
11/15/2007WO2007011367A3 Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16s ribosomal rna gene and identification of bacterial species by amplicon sequencing
11/15/2007WO2007001324A3 Methods and materials for determining pain sensitivity and predicting and treating related disorders
11/15/2007WO2006108135A8 Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways
11/15/2007WO2006086547A3 Automated biological indicator incubator
11/15/2007WO2006081580A3 System for and method of patch clamp analysis
11/15/2007WO2006078256A3 Polypeptides having xylanase activity and polynucleotides encoding same
11/15/2007WO2006076497A3 Osplation of pathogenic prions
11/15/2007WO2006075245A3 Systems, methods, and compositions for detection of human papilloma virus in biological samples
11/15/2007WO2006060171A3 Methods and compositions related to phage-nanoparticle assemblies
11/15/2007WO2006029014A3 rRNA OLIGONUCLEOTIDE PROBES FOR SPECIFIC DETECTION OF MYCOBACTERIA AND METHODS OF USE THEREOF
11/15/2007WO2006026602A3 Alternatively spliced pre-mrna transcripts in neurodegenerative disease
11/15/2007WO2006020899A3 Markers for autoimmune disease detection
11/15/2007WO2006018643A3 Electrochemical sensors
11/15/2007WO2005118878A3 Methods of screening for cell proliferation or neoplastic disorders
11/15/2007WO2005116261A3 Rna expression microarrays
11/15/2007WO2005100601A3 L-sign polymorphisms and methods involving use of same
11/15/2007WO2005059509A3 Biosensors for detecting macromolecules and other analytes
11/15/2007WO2005046572A3 Targeted delivery of controlled release polymer systems
11/15/2007WO2005044986A3 Methods and compositions for detection of segmented negative strand rna viruses
11/15/2007WO2005031303A3 Soluble phospholipids for use in clotting factor assays
11/15/2007WO2005023186A3 Methods of identifying agents that inhibit the growth of cancer cells
11/15/2007WO2005017105A3 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
11/15/2007WO2004085667A3 Methods and compositions for detecting the presence of target nucleic acids in a sample
11/15/2007WO2004058988A3 Binding agents which inhibit myostatin
11/15/2007WO2004048538A3 Csnks as modifiers of the rac pathway and methods of use